Validation of a Saliva-Based Test for the Molecular Diagnosis of SARS-CoV-2 Infection

Table 1

Demographic and clinical features of the case group.

	Patients ()
Age, median (IQR)	72 (62-77)
Days of symptoms before test, median (IQR)	12 (9-16)
Admission to ICU, (%)	34 (21.8)
Death, (%)	29 (18.6)
Admission to ICU or death, (%)	47 (30.1)